Essentialis, Inc.   Report issue

For profit Phase 3
Founded: Carlsbad CA United States (2003)
Status: Acquired by Soleno Therapeutics, Inc. (2016)

Organization Overview

First Clinical Trial
2008
NCT00688857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

atorvastatin (lipitor) (1 trial)

diazoxide choline (8 trials)

fenofibrate (fenoglide) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 2)

Hypertriglyceridemia (Phase 3)

Prader-Willi Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 3